Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA).

[1]  R. Bootzin,et al.  Chronic moderate sleep restriction in older long sleepers and older average duration sleepers: a randomized controlled trial. , 2013, Contemporary clinical trials.

[2]  G. Jean-Louis,et al.  Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. , 2013, Sleep.

[3]  P de Jonge,et al.  Anxiety disorders and inflammation in a large adult cohort , 2013, Translational Psychiatry.

[4]  A. Rodríguez-Rodríguez,et al.  Melatonin: Buffering the Immune System , 2013, International journal of molecular sciences.

[5]  Thomas C. Neylan,et al.  xaggerated neurobiological sensitivity to threat as a mechanism linking nxiety with increased risk for diseases of aging , 2012 .

[6]  J. Mullington,et al.  Sleep, inflammation and cardiovascular disease. , 2012, Frontiers in bioscience.

[7]  S. Ancoli-Israel,et al.  Sleep characteristics of self-reported long sleepers. , 2012, Sleep.

[8]  A. Beekman,et al.  Association of depressive disorders, depression characteristics and antidepressant medication with inflammation , 2012, Translational Psychiatry.

[9]  J. Dowd,et al.  Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. , 2011, Annals of epidemiology.

[10]  D. Goldberg,et al.  The heterogeneity of “major depression” , 2011, World psychiatry : official journal of the World Psychiatric Association.

[11]  G. Jean-Louis,et al.  LONG SLEEP A GREATER MORTALITY RISK THAN SHORT SLEEP IN OLDER ADULTS , 2011, Journal of the American Geriatrics Society.

[12]  J. Horne.  The end of sleep: ‘Sleep debt’ versus biological adaptation of human sleep to waking needs , 2011, Biological Psychology.

[13]  A. Harvey,et al.  Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms. , 2011, Clinical psychology review.

[14]  Daniel J Buysse,et al.  Are inflammatory and coagulation biomarkers related to sleep characteristics in mid-life women?: Study of Women's Health across the Nation sleep study. , 2010, Sleep.

[15]  George M. Slavich,et al.  Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion–biology relationships , 2010, Brain, Behavior, and Immunity.

[16]  A. Beekman,et al.  Cardiovascular Disease in Persons with Depressive & Anxiety Disorders , 2022 .

[17]  Thomas R Insel,et al.  Rethinking mental illness. , 2010, JAMA.

[18]  F. Cappuccio,et al.  Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. , 2010, Sleep.

[19]  B. Penninx,et al.  Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. , 2010, The Journal of clinical psychiatry.

[20]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[21]  Pasquale Strazzullo,et al.  Quantity and Quality of Sleep and Incidence of Type 2 Diabetes , 2009, Diabetes Care.

[22]  M. Marmot,et al.  Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. , 2009, Sleep.

[23]  S. Redline,et al.  Sleep duration and biomarkers of inflammation. , 2009, Sleep.

[24]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[25]  Daniel J. Buysse,et al.  Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications , 2008, Dialogues in clinical neuroscience.

[26]  P. Cuijpers,et al.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods , 2008, International journal of methods in psychiatric research.

[27]  Daniel J Buysse,et al.  Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. , 2008, Sleep.

[28]  S. Drummond,et al.  Who are the long sleepers? Towards an understanding of the mortality relationship. , 2007, Sleep medicine reviews.

[29]  T. Young,et al.  Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. , 2007, Sleep.

[30]  K. Matthews,et al.  Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women , 2007, Diabetes Care.

[31]  M. Irwin,et al.  Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. , 2006, Archives of internal medicine.

[32]  F. Hu,et al.  Correlates of long sleep duration. , 2006, Sleep.

[33]  B. Feige,et al.  Increased nocturnal interleukin-6 excretion in patients with primary insomnia: A pilot study , 2006, Brain, Behavior, and Immunity.

[34]  Jerry Suls,et al.  Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. , 2005, Psychological bulletin.

[35]  M. Irwin,et al.  Inflammatory Markers and Sleep Disturbance in Major Depression , 2005, Psychosomatic medicine.

[36]  D. Kripke,et al.  Long sleep and mortality: rationale for sleep restriction. , 2004, Sleep medicine reviews.

[37]  John Trinder,et al.  Sick and tired: does sleep have a vital role in the immune system? , 2004, Nature Reviews Immunology.

[38]  E. Bixler,et al.  Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. , 2004, The Journal of clinical endocrinology and metabolism.

[39]  A. Sherwood,et al.  Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment , 2004, Psychosomatic medicine.

[40]  M. Höfler,et al.  Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS) , 2004, Psychological Medicine.

[41]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[42]  D. Kripke,et al.  Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale. , 2003, Psychological assessment.

[43]  D. Kripke,et al.  Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. , 2003, Psychological assessment.

[44]  J. Manson,et al.  A prospective study of self-reported sleep duration and incident diabetes in women. , 2003, Diabetes care.

[45]  Atul Malhotra,et al.  A prospective study of sleep duration and coronary heart disease in women. , 2003, Archives of internal medicine.

[46]  R. de Graaf,et al.  Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders , 2003, Social Psychiatry and Psychiatric Epidemiology.

[47]  Pauline Heslop,et al.  Sleep duration and mortality: The effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. , 2002, Sleep medicine.

[48]  E. Zorrilla,et al.  The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review , 2001, Brain, Behavior, and Immunity.

[49]  D F Dinges,et al.  Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. , 2001, The Journal of allergy and clinical immunology.

[50]  D. Papanicolaou,et al.  Circadian interleukin-6 secretion and quantity and depth of sleep. , 1999, The Journal of clinical endocrinology and metabolism.

[51]  Josep M. Guerrero,et al.  Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. , 1997, Journal of immunology.

[52]  D. Ford,et al.  Depression and Risk for Onset of Type II Diabetes: A prospective population-based study , 1996, Diabetes Care.

[53]  J. McLachlan,et al.  Activation of human monocytes by the pineal hormone melatonin. , 1994, Journal of immunology.

[54]  H. Wittchen.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. , 1994, Journal of psychiatric research.

[55]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.